The study suggests simplifying guidelines to recommend low-dose aspirin for pregnant individuals with any single moderate-risk factor for preeclampsia.
These data support the recently published guidelines and suggest further simplified guidelines recommending LDA to patients with any single moderate-risk factors.
Wheeler et al. (2022) studied this question.